WebIn the first study, 85% of nurses and 78% of patients preferred the Imraldi autoinjector over the Humira autoinjector (P < 0.001); in the second study, 86% of nurses and 79% of patients preferred the Imraldi autoinjector over the Enbrel MyClic autoinjector (P < 0.001). WebMar 24, 2024 · Introduction The objective of this report was to evaluate perceptions of psoriatic arthritis (PsA) treatment and satisfaction with healthcare professional (HCP) communication among patients with PsA in Australia, compared with overall global perceptions. Methods Data were collected via a global and country-specific survey (The …
Editor
WebPhilip Mease MD, MACR Seattle Rheumatology Associates (Swedish Orthopedic Institute) – Providence Connect Director, Rheumatology Research, Swedish Medical Center/ Providence St. Joseph Health Clinical Professor, University of Washington School of Medicine 26thAnnual Pain Management Symposium 10/7/2024 2 P Mease Disclosures WebJun 17, 2024 · The comparison of the coefficients using the 95% confidence interval showed that MASES had a better correlation with BASDAI compared to LEI (p = 0.018).There was no statistical difference between MASES and SPARCC (p = 0.212) or between SPARCC and LEI (p = 0.14).In the analysis of ROC curves, the three enthesitis scores could discriminate … sanfran ashok city jhansi
Understanding the association between skin involvement and …
WebFibromyalgia syndrome (sFM) is one of the most common causes of chronic pain. This study aimed to assess the presence of small and large fiber impairment in fibromyalgic patients by applying validated scores used in the screening for diabetic neuropathy. The endpoints for the study were the assessment of neuropathy prevalence in sFM patients … WebClin Exp Rheumatol. 2024;37(4):566–574. 31. Smolen JS, Mease P, Tahir H, et al. Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus Adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52. WebP.J. Mease, MD, Clinical Professor, Swedish Medical Center and University of Washington; M. Heckaman, MS, Statistical Analyst, AbbVie, USA; S. Kary, MD, Immunoscience Division; H. Kupper, MD, Senior Medical Director, Immunology, AbbVie Deutschland GmbH & Co. KG. Address correspondence to Dr. P.J. Mease, Seattle Rheumatology Associates, 601 … san fran bicycle coalition